Russian_Flashbang

Hi, Todd, thanks for doing this AMA! I have a couple of questions, if you don't mind answering.
* How many cases of PAM arise in the United States per year and is infection by negleria fowleri more likely in any particular climates or regions, e.g. warmer bodies of fresh water in southeastern states vs. colder bodies of water in, say, the Pacific Northwest?

*Regarding your proposed consignment program for Impavido, are there any examples of existing consignment programs in which drug companies stock hospitals with other life-saving drugs such as antivenin? Surely PAM isn't the only drug designed to treat illnesses in which time is such a serious factor. A consignment program like the one you propose seems like a no-brainer--hospitals get life-saving medicine for free and only have to pay for it when it's used.

Thank you for taking the time to do this AMA. In a world where most pharma CEOs seem to have gone to the Martin Shkreli school of business, it's nice to know there's at least one decent person like you out there in the pharmaceutical business.

Thanks for answering! Good luck with your consignment program!